170 related articles for article (PubMed ID: 37526500)
1. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
[TBL] [Abstract][Full Text] [Related]
2. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
[No Abstract] [Full Text] [Related]
3. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
[TBL] [Abstract][Full Text] [Related]
4. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
Ikeda K; Kakehi E; Adachi S; Kotani K
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
[TBL] [Abstract][Full Text] [Related]
5. Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review.
Masiak A; Lass A; Kowalski J; Hajduk A; Zdrojewski Z
Rheumatol Int; 2022 Feb; 42(2):341-348. PubMed ID: 35024942
[TBL] [Abstract][Full Text] [Related]
6. Kikuchi-Fujimoto Disease and Prognostic Implications.
Salamat S; Chan J; Jolly K; Powell G; Harrison K; Ahanger S; Hari C
Head Neck Pathol; 2020 Mar; 14(1):272-275. PubMed ID: 30888636
[TBL] [Abstract][Full Text] [Related]
7. Histology-Independent Signature Distinguishes Kikuchi-Fujimoto Disease/Systemic Lupus Erythematosus-Associated Lymphadenitis From Benign and Malignant Lymphadenopathies.
Scott GD; Kumar J; Oak JS; Boyd SD; Raess PW; Gratzinger DA
Am J Clin Pathol; 2020 Jul; 154(2):215-224. PubMed ID: 32367142
[TBL] [Abstract][Full Text] [Related]
8. Strong association of Torque teno virus/Torque teno-like minivirus to Kikuchi-Fujimoto lymphadenitis (histiocytic necrotizing lymphadenitis) on quantitative analysis.
Chong Y; Lee JY; Thakur N; Kang CS; Lee EJ
Clin Rheumatol; 2020 Mar; 39(3):925-931. PubMed ID: 31782015
[TBL] [Abstract][Full Text] [Related]
9. Kikuchi-Fujimoto disease following vaccination against COVID-19.
Guan Y; Xia X; Lu H
J Hematop; 2022 Mar; 15(1):21-23. PubMed ID: 35284024
[TBL] [Abstract][Full Text] [Related]
10. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis.
Watanabe T; Hashidate H; Hirayama Y; Iinuma Y
Eur J Pediatr; 2012 Sep; 171(9):1409-11. PubMed ID: 22476507
[TBL] [Abstract][Full Text] [Related]
11. Kikuchi-Fujimoto Disease Post COVID-19 Vaccination: Case Report and Review of Literature.
Tan HM; Hue SS; Wee A; See KC
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835182
[TBL] [Abstract][Full Text] [Related]
12. Kikuchi-Fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report.
Cho E; Baek HJ; Bae K; Jeon KN; Moon JI; Park SE; Lee HS; An HJ
Curr Med Imaging; 2023 Jun; ():. PubMed ID: 37340742
[TBL] [Abstract][Full Text] [Related]
13. A familial case of Kikuchi-Fujimoto disease in dizygotic twins.
Quadir A; Peacock K; Hsu P; Singh-Grewal D; Alexander S
Pediatr Rheumatol Online J; 2020 Aug; 18(1):62. PubMed ID: 32778173
[TBL] [Abstract][Full Text] [Related]
14. The fine-needle aspiration cytology and clinical findings of Kikuchi-Fujimoto disease in pediatric patients: a retrospective clinical study.
Naoi Y; Tachibana T; Wani Y; Hotta M; Haruna K; Komatsubara Y; Kuroda K; Fushimi S; Nagatani T; Kataoka Y; Nishizaki K; Sato Y; Ando M
Acta Otolaryngol; 2022; 142(3-4):340-344. PubMed ID: 35235442
[TBL] [Abstract][Full Text] [Related]
15. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.
Caocci G; Fanni D; Porru M; Greco M; Nemolato S; Firinu D; Faa G; Scuteri A; La Nasa G
Haematologica; 2022 May; 107(5):1222-1225. PubMed ID: 34965702
[No Abstract] [Full Text] [Related]
16. Necrotizing lymphadenitis: Kikuchi--Fujimoto disease alias lupus lymphadenitis?
Cramer J; Schmiedel S; Alegre NG; Schäfer H; Burchard GD; Merz H
Lupus; 2010 Jan; 19(1):89-92. PubMed ID: 19933723
[TBL] [Abstract][Full Text] [Related]
17. Kikuchi-Fujimoto disease. Histiocytic necrotizing lymphadenitis.
Al-Maghrabi JA
Saudi Med J; 2011 Nov; 32(11):1111-21. PubMed ID: 22057597
[TBL] [Abstract][Full Text] [Related]
18. A rare encounter: Kikuchi-Fujimoto disease presenting atypically after BNT162b2 COVID-19 vaccination: a case report.
Nam KH; Choi Y
Scand J Rheumatol; 2023 Nov; 52(6):705-707. PubMed ID: 37606559
[No Abstract] [Full Text] [Related]
19. Clinicopathologic Analysis of Kikuchi-Fujimoto Disease and Etiologic Exploration Using Metagenomic Next-Generation Sequencing.
Wang W; Huang S; Nong L; Li X; Li D; Zhang B; Li T
Arch Pathol Lab Med; 2023 Jul; 147(7):767-773. PubMed ID: 36308713
[TBL] [Abstract][Full Text] [Related]
20. Fatal Kikuchi-Fujimoto disease: the lupus connection.
Quintás-Cardama A; Fraga M; Cozzi SN; Caparrini A; Maceiras F; Forteza J
Ann Hematol; 2003 Mar; 82(3):186-8. PubMed ID: 12634955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
